Last reviewed · How we verify
On Metformin
Metformin, a first-line treatment for type 2 diabetes, is being evaluated in multiple clinical trials for new indications and drug interactions. Recent studies focus on its potential in cystic fibrosis-related diabetes, tuberculosis, and HIV. Despite no FDA label, it remains a cornerstone in diabetes management.
At a glance
| Generic name | On Metformin |
|---|---|
| Sponsor | German Diabetes Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- On Metformin CI brief — competitive landscape report
- On Metformin updates RSS · CI watch RSS
- German Diabetes Center portfolio CI